ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 185 filers reported holding ACCELERON PHARMA INC in Q4 2019. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $11,527,000 | -30.5% | 90,100 | -38.9% | 0.03% | -34.0% |
Q3 2020 | $16,587,000 | +40.7% | 147,400 | +19.2% | 0.05% | +34.3% |
Q2 2020 | $11,785,000 | +179.0% | 123,700 | +163.2% | 0.04% | +118.8% |
Q1 2020 | $4,224,000 | +860.0% | 47,000 | +466.3% | 0.02% | +1500.0% |
Q4 2019 | $440,000 | -77.7% | 8,300 | -83.4% | 0.00% | -80.0% |
Q3 2019 | $1,972,000 | -28.7% | 49,900 | -25.9% | 0.01% | -28.6% |
Q2 2019 | $2,765,000 | -15.5% | 67,300 | -4.3% | 0.01% | -12.5% |
Q1 2019 | $3,274,000 | – | 70,300 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 42,030 | $3,777,000 | 6.01% |
Artal Group S.A. | 1,500,000 | $134,805,000 | 5.70% |
GREAT POINT PARTNERS LLC | 535,627 | $48,137,000 | 5.03% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 211,038 | $18,966,000 | 3.47% |
Cormorant Asset Management, LP | 825,000 | $74,143,000 | 3.44% |
Graticule Asia Macro Advisors LLC | 48,700 | $4,377,000 | 3.20% |
Avoro Capital Advisors LLC | 860,000 | $77,288,000 | 2.61% |
QVT Financial LP | 120,264 | $10,808,000 | 2.52% |
Ikarian Capital, LLC | 316,900 | $28,480,000 | 2.14% |
Avidity Partners Management LP | 166,000 | $14,918,000 | 2.06% |